Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$431M |
| 2 |
Truist Financial
TFC
|
+$346M |
| 3 |
Alibaba
BABA
|
+$238M |
| 4 |
ServiceNow
NOW
|
+$228M |
| 5 |
Corteva
CTVA
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$875M |
| 2 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$395M |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$340M |
| 4 |
Oracle
ORCL
|
+$197M |
| 5 |
Apple
AAPL
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.13% |
| 2 | Financials | 14.48% |
| 3 | Healthcare | 12.77% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3476
LiveOne
LVO
$62.8M
| $742K | ﹤0.01% |
48,021
+9,675
| +25% | +$167K |
|
|
AXAS
3477
DELISTED
Abraxas Petroleum Corp
AXAS
| $742K | ﹤0.01% |
105,694
-6,295
| -6% | -$40.6K |
|
3478
Nexa Resources
NEXA
$1.91B
| $741K | ﹤0.01% |
91,044
+14,480
| +19% | +$132K |
|
|
TCS
3479
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $741K | ﹤0.01% |
11,701
-834
| -7% | -$52.9K |
|
|
LEAF
3480
DELISTED
Leaf Group Ltd.
LEAF
| $738K | ﹤0.01% |
184,495
-8,138
| -4% | -$29.9K |
|
3481
Organogenesis Holdings
ORGO
$243M
| $737K | ﹤0.01% |
153,362
+37,238
| +32% | +$236K |
|
3482
Bridgford Foods
BRID
$57.7M
| $735K | ﹤0.01% |
29,662
-749
| -2% | -$19.2K |
|
3483
Cohen & Steers REIT and Preferred and Income Fund
RNP
$971M
| $735K | ﹤0.01% |
30,891
| – | – |
|
3484
Mayville Engineering Co
MEC
$574M
| $733K | ﹤0.01% |
78,174
+216
| +0.3% | +$2.24K |
|
3485
IAMGOLD
IAG
$10.4B
| $728K | ﹤0.01% |
195,079
-1,110
| -0.6% | -$3.93K |
|
3486
Bank7 Corp
BSVN
$486M
| $727K | ﹤0.01% |
38,338
-662
| -2% | -$12.4K |
|
|
ASNA
3487
DELISTED
Ascena Retail Group, Inc.
ASNA
| $721K | ﹤0.01% |
94,010
-6,755
| -7% | -$55.4K |
|
3488
iShares Silver Trust
SLV
$31.5B
| $711K | ﹤0.01% |
42,650
-2,180
| -5% | -$35.3K |
|
3489
Sixth Street Specialty
TSLX
$1.78B
| $709K | ﹤0.01% |
33,004
+8,400
| +34% | +$179K |
|
|
BXRX
3490
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
| $707K | ﹤0.01% |
+73
| New | +$623K |
|
3491
Cibus
CBUS
$145M
| $705K | ﹤0.01% |
2,012
-179
| -8% | -$44.9K |
|
3492
Gyre Therapeutics
GYRE
$704M
| $705K | ﹤0.01% |
13,797
+1,286
| +10% | +$53.9K |
|
|
YARW
3493
Yarrow Bioscience, Inc. Common Stock
YARW
$115M
| $699K | ﹤0.01% |
42
-2
| -5% | -$33.3K |
|
3494
Vince Holding Corp
VNCE
$74.4M
| $694K | ﹤0.01% |
40,144
-1,032
| -3% | -$21.6K |
|
|
MJCO
3495
DELISTED
Majesco
MJCO
| $694K | ﹤0.01% |
84,052
+1,538
| +2% | +$13K |
|
|
RVLP
3496
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $693K | ﹤0.01% |
99,166
+11,357
| +13% | +$60.6K |
|
3497
Celcuity
CELC
$4.3B
| $691K | ﹤0.01% |
64,970
+8
| +0% | +$105 |
|
3498
MidCap Financial Investment
MFIC
$804M
| $681K | ﹤0.01% |
38,974
-820
| -2% | -$13.5K |
|
|
SHI
3499
DELISTED
Sinopec Shanghai Petrochemical Co., Ltd.
SHI
| $678K | ﹤0.01% |
22,183
-386
| -2% | -$11K |
|
3500
Neurogene
NGNE
$714M
| $675K | ﹤0.01% |
2,738
+411
| +18% | +$40.9K |
|
Similar funds
Northern Trust's Q4 2019 Portfolio in Review
As of Q4 2019, Northern Trust held 4,386 positions worth $447B, up 7% from $418B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Northern Trust's Q4 2019 filing shows 134 new, 1,479 increased, 2,453 reduced and 124 closed positions. Its largest new stake was Envista: 706,517 shares worth $20.9M. The largest sale was Celgene Corp, an estimated $875M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q4 2019 buy was Envista: 706,517 shares worth $20.9M.
- Northern Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $431M increase.
- Northern Trust's biggest Q4 2019 reduction was FlexShares Global Upstream Natural Resources Index Fund, cutting an estimated $395M.
- Northern Trust fully exited Celgene Corp in Q4 2019, selling an estimated $875M.
- Northern Trust's ten largest holdings make up 17% of its $447B portfolio in Q4 2019.
- Northern Trust opened 134 new positions and closed 124 in Q4 2019.
- Northern Trust's portfolio value rose 7% quarter-over-quarter to $447B.
Based on Northern Trust's 13F filing for Q4 2019, filed 14 Feb 2020.